- Home
- RDIB vs CSBR Comparison
RDIB vs CSBR Comparison
Compare RDIB & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDIB
- CSBR
- Stock Information
- Founded
- RDIB 1937
- CSBR 1985
- Country
- RDIB United States
- CSBR United States
- Employees
- RDIB N/A
- CSBR N/A
- Industry
- RDIB Movies/Entertainment
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDIB Consumer Discretionary
- CSBR Health Care
- Exchange
- RDIB Nasdaq
- CSBR Nasdaq
- Market Cap
- RDIB 140.2M
- CSBR 113.0M
- IPO Year
- RDIB N/A
- CSBR 1986
- Fundamental
- Price
- RDIB $9.51
- CSBR $8.24
- Analyst Decision
- RDIB
- CSBR Strong Buy
- Analyst Count
- RDIB 0
- CSBR 1
- Target Price
- RDIB N/A
- CSBR $12.00
- AVG Volume (30 Days)
- RDIB 6.7K
- CSBR 38.4K
- Earning Date
- RDIB 08-13-2025
- CSBR 07-17-2025
- Dividend Yield
- RDIB N/A
- CSBR N/A
- EPS Growth
- RDIB N/A
- CSBR N/A
- EPS
- RDIB N/A
- CSBR 0.46
- Revenue
- RDIB $205,644,000.00
- CSBR $58,591,000.00
- Revenue This Year
- RDIB $7.47
- CSBR $15.11
- Revenue Next Year
- RDIB $13.22
- CSBR $7.80
- P/E Ratio
- RDIB N/A
- CSBR $17.82
- Revenue Growth
- RDIB N/A
- CSBR 19.03
- 52 Week Low
- RDIB $5.78
- CSBR $3.60
- 52 Week High
- RDIB $21.34
- CSBR $11.99
- Technical
- Relative Strength Index (RSI)
- RDIB 45.18
- CSBR 69.99
- Support Level
- RDIB $9.00
- CSBR $6.27
- Resistance Level
- RDIB $12.72
- CSBR $8.58
- Average True Range (ATR)
- RDIB 1.33
- CSBR 0.64
- MACD
- RDIB -0.12
- CSBR 0.28
- Stochastic Oscillator
- RDIB 19.13
- CSBR 96.63
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.